1. P1207: MULTICENTER RANDOMIZED CONTROLLED (COMPARATIVE) OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF THE R-DA-EPOCH-21 AND R-MNHL-BFM-90 ± AUTO- HSCT PROGRAMS IN PATIENTS WITH DE NOVO DIFFUSE B-CELL LAR. (23rd June 2022) Authors: Magomedova, A.; Kravchenko, S.; Misyurina, A.; Mangasarova, Y.; Margolin, O.; Fastova, E.; Babaeva, F.; Gorenkova, L.; Bagova, M.; Nesterova, E.; Sychevskaya, K.; Moiseeva, T.; Kovrigina, A.; Obukhova, T.; Dvirnyk, V.; Galtseva, I.; Galuzyak, V.; Maryina, S.; Danishyan, K.; Kostina, I. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1093 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PB2021: QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD): RESULTS OF A REAL-WORLD EVIDENCE STUDY. (23rd June 2022) Authors: Ionova, T.; Vinogradova, O.; Kochkareva, Y.; Ado, E.; Kaplanov, K.; Shirokova, M.; Shelekhova, T.; Levanov, A.; Kopylova, A.; Li, O.; Mitina, T.; Rukavitsyn, O.; Simashova, P.; Anchukova, L.; Babich, E.; Dasheeva, D.; Demchenkova, M.; Dubov, S.; Esenina, T.; Ivanova, L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1892 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗